SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-069210
Filing Date
2023-12-11
Accepted
2023-12-11 09:17:48
Documents
16
Period of Report
2023-12-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prld-20231211.htm   iXBRL 8-K 69034
2 EX-4.1 prld-ex4_1.htm EX-4.1 131413
3 EX-99.1 prld-ex99_1.htm EX-99.1 14371
4 GRAPHIC img268059179_0.jpg GRAPHIC 5700
  Complete submission text file 0000950170-23-069210.txt   410210

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prld-20231211_lab.xml EX-101.LAB 21206
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prld-20231211.xsd EX-101.SCH 2900
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prld-20231211_def.xml EX-101.DEF 13488
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prld-20231211_pre.xml EX-101.PRE 13615
10 EXTRACTED XBRL INSTANCE DOCUMENT prld-20231211_htm.xml XML 6001
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39527 | Film No.: 231477068
SIC: 2834 Pharmaceutical Preparations